Type 2 & other diabetes

Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (Joint Asian Diabetes Evaluation (JADE)) Register

Diabetes Res Clin PractPublished Retrospective cross-sectional analysis of the JADE Register

Authors' conclusion

Demographic, physical and psychosocial-behavioural factors were associated with HRQoL in patients with T2DM. Our real-world data add to previous evidence that gliclazide is an effective OGLD, with most treated patients reporting good HRQoL. A plain language summary of this manuscript is available here.

Study context

Population
Adults with T2D from 11 Asian countries/regions enrolled in the JADE Register (2007–2019) with EQ-5D-3L data
Participants
47,895 adults
Exposure
Oral glucose-lowering drugs (OGLDs) + lifestyle modifications vs lifestyle modifications only
  • OGLD + lifestyle modifications (LSM)n = 42,813
  • LSM onlyn = 5,082reference
Outcome
HRQoL (EQ-5D-3L) and associated factors
Methodological detailsprospectively enrolled register, 11 Asian countries/regions
  • Prospectively enrolled register
  • 11 Asian countries/regions

Main finding

As reported in the abstract

Mean EQ-5D-3L index score

Most affected EQ-5D-3L dimensions in OGLD + LSM: pain/discomfort

26.2%

Most affected EQ-5D-3L dimensions in OGLD + LSM: anxiety/depression

22.6%

Observational data: associations, not effects.

Further findings

OutcomeP value
HbA1c and HRQoL, gliclazide vs non-gliclazide SUsP < 0.001
  • HbA1c and health-related quality of life (HRQoL), gliclazide vs non-gliclazide SUs: lower HbA1c and better HRQoL in all dimensions with gliclazide

SU use among OGLD-treated

Received SUs
60%
Received gliclazide among SU users
47%

Original publication

Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) Register. Diabetes Res Clin Pract. Published 28 July 2023. doi:10.1016/j.diabres.2023.110855

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.